As of Jun 29, 2018 Zosano Pharma Corporation (NASDAQ:ZSAN) Sellers Decreased Their Shorts By 43.02%

June 29, 2018 - By Alice Reed

It was registered a decrease on Zosano Pharma Corporation (NASDAQ:ZSAN)’s shorted shares with 43.02%. FINRA announced shorted shares of ZSAN’s total 924,200 shares. That’s 43.02% down from 1.62M shares. 2 days will cost ZSAN with 523,600 average volume to restore its former position. 2.89% is Zosano Pharma Corporation float short.

ZSAN is touching $4.06 during the last trading session, after increased 2.01%.Zosano Pharma Corporation has volume of 185,578 shares. Since June 29, 2017 ZSAN has declined 85.30% and is downtrending. The stock underperformed the S&P500 by 97.87%.

Zosano Pharma Corporation, a clinical stage pharmaceutical company, develops a proprietary intracutaneous delivery system to administer drugs through the skin for rapid symptom relief to patients.The firm is valued at $48.61 million. The Company’s lead product candidate is M207, a proprietary formulation of zolmitriptan used for the treatment of migraine.Currently it has negative earnings.

For more Zosano Pharma Corporation (NASDAQ:ZSAN) news announced briefly go to: Streetinsider.com, Benzinga.com, Benzinga.com, Streetinsider.com or Streetinsider.com. The titles are as follows: “After-Hours Stock Movers 06/27: (EDGE) (ZSAN) (MSG) Higher; (PIR) (BBBY) (XON) Lower (more…)” announced on June 27, 2018, “5 Stocks Moving In Wednesday’s After-Hours Session” on June 27, 2018, “40 Stocks Moving In Thursday’s Mid-Day Session” with a publish date: June 28, 2018, “UPDATE: BTIG Starts Zosano Pharma (ZSAN) at Buy” and the last “Pre-Open Movers 06/28: (DRRX) (ZSAN) (CAVM) Higher; (ASNS) (PIR) (WBA) Lower (more…)” with publication date: June 28, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.